Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
A. Scherpereel (Lille, France). Biomarkers in clinical decision making. Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers for clinical management Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Lung ultrasound may be a valuable aid in decision making for patients admitted with COVID-19 disease Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Improving GINA adoption by designing a mobile based clinical decision support system Source: International Congress 2018 – Variant forms of asthma Year: 2018 Patient preferences for information and involvement in clinical decision making: distinct entities in the patient-pulmonologist encounter Source: Eur Respir J 2004; 24: Suppl. 48, 282s Year: 2004 How to use monitoring data to make wise clinical decisions Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients Year: 2015 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 Shared decision making in severe asthma therapy: qualitative study of physician-patient communication Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Selecting patients in clinical practice Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation Year: 2012 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 Models of translating clinical research into practice Source: Annual Congress 2008 - MP6 - Role of allied respiratory professionals in clinical research Year: 2008 Public understanding and informed decision making: keys to a successful screening programme Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020 Year: 2020 Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection Source: ERJ Open Res, 4 (1) 00146-2017; 10.1183/23120541.00146-2017 Year: 2018 Clinical phenotyping: role in treatment decisions in sarcoidosis Source: Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019 Year: 2020 Biomarkers and personalised treatment Source: Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment Year: 2012